It was found that overexpression of RSPO2 and RSPO3 was presented by 4-10% of colon subjects (54) and recurrent R-spondin fusions in colon cancer activate the Wnt signaling and increase the tumorigenesis (57). This evidence concerns the gene RSPO2 and malignant colon neoplasm.